SANTA BARBARA, CA, July 26, 2026. Santa Barbara Nutrients (SBN) is pleased to announce the publication of a new peer reviewed case series in Frontiers in Nutrition demonstrating that the long term Ren-Nu™ ketogenic metabolic therapy, combined with SBN’s medical...
FOR IMMEDIATE RELEASE SANTA BARBARA, CA – May 20, 2026 – Santa Barbara Nutrients (SBN) is pleased to announce the 12-month interim results from an ongoing clinical trial evaluating the safety and efficacy of SBN’s medical food KetoCitra® in combination...
A new clinical trial led by the Cleveland Clinic is evaluating a ketogenic nutrition-based approach using Ren-Nu™ and KetoCitra® to address the metabolic drivers of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The study will assess safety, feasibility, and metabolic and...
FOR IMMEDIATE RELEASE SANTA BARBARA, CA – Santa Barbara Nutrients (SBN) is pleased to announce the first interim results from an ongoing clinical trial to study the safety and efficacy of SBN’s medical food KetoCitra® in combination with education on...
FOR IMMEDIATE RELEASE Santa Barbara Nutrients Announces Publication of Peer-Reviewed Study Reporting Real-World Outcomes of Ren-Nu™ Program for Polycystic Kidney Disease Santa Barbara, CA — January 21, 2026 — Santa Barbara Nutrients, Inc., a science-driven biotechnology and nutrition company focused on...
